Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone in Patients with COPD-A Cost-Effectiveness Analysis in the Czech Republic. [electronic resource]
Producer: 20190107Description: 112-118 p. digitalISSN:- 2212-1102
- Bronchodilator Agents -- administration & dosage
- Cost-Benefit Analysis
- Czech Republic
- Female
- Fluticasone-Salmeterol Drug Combination -- administration & dosage
- Glycopyrrolate -- administration & dosage
- Humans
- Indans -- administration & dosage
- Male
- Muscarinic Antagonists -- administration & dosage
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Quality-Adjusted Life Years
- Quinolones -- administration & dosage
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.